Trial NCT04760288

View at ClinicalTrials.gov 
Org. Study IDs: CO42865
Secondary IDs: 2020-005269-15

Last trial update was posted on 2024-01-05

MeSH Interventions

Pralsetinib

MeSH Conditions

Carcinoma, Neuroendocrine Thyroid Diseases Thyroid Neoplasms

Other Conditions

Medullary Thyroid Cancer

Stopping Reasons

Due to several logistical challenges during start-up which could not be overcome study was withdrawn.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID